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Abstract 
We measured carnitine palmitoyl transferase activity, free carnitine, and long chain acyl carnitine levels in erythrocytes from 15 
uremic patients and 25 controls. Carnitine palmitoyl transferase l vels in patients were significantly lower than in controls. The levels of 
free carnitine and long chain acyl carnitines as well as the long chain acyl carnitine/free carnitine ratio were significantly higher in 
patients than in controls. Our results uggest that hemodialysis causes alteration i  the acyl-trafficking in red blood cells membrane. 
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1. Introduction 
Erythrocyte carnitine palmitoyl transferase (CPT) is 
involved in the membrane phospholipid (PL) fatty acid 
turnover of human red blood cells (RBC) [1-3]. The 
reversible transfer of long chain fatty acids from CoA to 
L-carnitme, catalyzed by RBC CPT, modulates the acyl 
CoA/free CoA ratio, which is critical for the regulation of 
the membrane PL fatty acid turnover [1]. Long chain acyl 
carnitines (LCAC) serve as a reservoir of acyl-moieties for 
the reacylation of membrane PL, which is catalyzed by 
lysophospholipid acyl-CoA transferase (LAT) [2]. 
Human erythrocytes have been shown to have signifi- 
cant amounts of L-carnitine and its esters [4,5]. Because 
RBC carnitines do not freely exchange with plasma, their 
presence in mature erythrocytes seems to stem from the 
reminiscent function of erythrocyte precursors [4]. RBC 
carnitine levels seem to regulate the activities of some 
enzymes of human erythrocyte membranes, as well as their 
molecular properties uch as stability and rigidity [6]. 
Abbreviations: CPT, carnitine palmitoyl transferase; PL, phospho- 
lipid; RBC, erythrocytes: LCAC, long-chain acyl carnitines; LAT, 
lysophospholipid acyI-CoA transferase; FC, free carnitine; COX. cy- 
tochrome-c oxidase. 
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In this work, we studied CPT and carnitine levels in 
RBC from both normal subjects and hemodialysis patients. 
2. Materials and methods 
2.1. Materials 
L-Methyl-3[H]carnitine hydrochloride (60 Ci/mmol) 
was obtained from Amersham Iberica (Madrid), [l- 
HC]acetyl-CoA (40 mCi/mmol) was from ICN Radio- 
chemical (Irvine, USA). Carnitine acetyltransferase and 
phenyl-methane-sulphonyl-fluoride (PMSF) were pur- 
chased from Boehringer Mannheim, FRG. Palmitoyl CoA 
was from Sigma Chemical CO (St. Louis MO, USA). All 
other reactives used were reagent grade. 
2.2. Subjects 
Blood samples were drawn from 15 chronically uremic 
patients (7 female, 8 male; aged 55.7 _+ 11.4, range 40-72 
years) undergoing regular hemodialysis treatment during 
13 years. Also, blood samples were taken from 25 age- 
matched healthy controls (13 male, 12 female; aged 56 _+ 
10, range 42-70 years). 
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2.3. Preparation of  washed RBC and ghosts 3. Results and discussion 
Venous blood was collected before dialysis, in the 
morning, and after fasting in heparin or EDTA. Leuko- 
cytes and platelets were removed by passage through a 
column of c~-cellulose and microcrystalline cellulose [7]. 
RBC were then washed three times with cold 0.9% NaCI. 
Membrane ghosts were prepared from washed hep- 
arinized cells which were lysed in 30 Vols. of cold lysing 
buffer (5 mM NaH2PO 4, pH 7.4, 0.1 mM PMSF). The 
lysed cells were then centrifuged for 10 min at 30 000 × g 
at 4°C, and the resulting pelleted ghosts were washed four 
times. The ghosts were collected then in 5 mM NaH2 PO4 
(pH 7.4). Protein concentration was determined according 
to Bradford [8]. 
2.4. CPT assay 
The activity was measured in ghosts RBC by a radio- 
chemical procedure [9] in 220 mM sucrose/40 mM 
KC1/10 mM Tris/HC1 (pH 7.4 at 30°C)/1 mM EGTA, 
except that the final concentration of palmitoyl CoA was 
50 /xM, with 1.3 mg of BSA/ml ;  L-[3H]carnitine was 1 
mM, and the time of incubation was 30 min. 
2.5. LCAC and FC determinations 
LCAC and FC levels were measured by an optimized 
radiochemical enzymatic assay [10] in washed RBC col- 
lected in EDTA. Modifications were done as previously 
described [11]. 
2.6. Cytochrome-c oxidase (COX) activity 
The activity was determined in ghosts RBC, by moni- 
toring the decrease in absorbance at 550 nm of reduced 
cytochrome c [12]. Reduced cytochrome c was prepared 
fresh before each experiment by adding a few grains of 
sodium hydrosulfide to a 1% solution in 10 mM K-Phos- 
phate buffer (pH 7.0) 
2.7. Statistical analysis 
Statistical analysis was performed by Student's t-test. 
Membrane PL fatty acid turnover in human RBC de- 
pends on the activities of both long chain acyl CoA 
synthetase and LAT [2]. The former generates acyl CoA 
from free fatty acids and CoA, while the latter reacylates 
lysophospholipids by using acyl CoA as substrate. When 
the rate of formation of acylCoA becomes different from 
that of its utilization for reacylation, acyl CoA pool and the 
acylCoA/free CoA ratio become altered, leading to distur- 
bances in RBC PL fatty acid turnover [1]. RBC CPT 
maintains a favorable acyl CoA/ f ree  CoA ratio by form- 
ing acylcarnitine from carnitine and acyl CoA [1]. 
We found significantly reduced CPT levels in RBC 
from patients on HD compared with those of controls 
(Table 1). To assess whether the total CPT activity mea- 
sured in RBC membrane preparations was contaminated 
with CPT activity from reticulocyte mitochondria, we de- 
termined the activity of cytochrome-c oxidase (COX), a 
mitochondrial membrane marker, in membrane prepara- 
tions from 6 patients and 5 controls [1]. Activities of COX 
were very poor and similar in both controls (0.55 +_ 0.08 
nmol /min /mg protein; mean _+ S.D.) and patients (0.57 
_+ 0.05 nmol /min /mg protein; mean + S.D.). These data 
clearly indicate that the activity of CPT in membrane 
preparations is mostly contributed by RBC membranes, 
and that there is scant contamination with reticulocyte 
mitochondria. 
The decrease in RBC CPT levels may cause similar 
consequences to those observed after CPT inhibition by 
2-tetradecylglycidic or palmitoyl-D-carnitine [1]. Under 
such circumstances, the lack of buffering activity of CPT 
alters the acylCoA/free CoA ratio, and eventually the 
availability of fatty acid moieties for reacylation. Addition- 
ally, the relatively high concentrations of free CoA may 
further act as an inhibitor of the enzyme LAT. We suggest 
that the reduction in RBC CPT activity alters erythrocyte 
PL turnover, impeding the repairing of fatty acids damaged 
by free radicals, and ultimately leading to accumulation of 
lysophospholipids. The latter may be involved in the ane- 
mia and hemolysis from uremic patients. 
In controls, we found levels of RBC carnitines similar 
to those previously documented [4,5]. In hemodialysis 
patients, RBC FC and LCAC values did not differ from 
Table 1 
Levels of FC, LCAC, CPT and LCAC/FC ratio in red blood cells from HD patients and controls 
FC LCAC LCAC / FC CPT 
Controls (n = 25) 58.5 ___ 21.1 8.53 + 2.81 0.15 ___ 0.04 0.42 ± 0.14 
HD Patients (n = 15) 103.5 ± 32.2 b 19.9 ± 8.48 b 0.20 ± 0.06 a 0.32 ± 0.17 a 
FC, Free carnitine; LCAC, long chain acyl-carnitine; CPT, carnitine palmitoyl transferase. 
FC and LCAC are in nmol • glib- 1, and CPT is in nmol. min- i . mg protein- I. Data indicated are mean + S.D. 
a Significant differences vs controls (P(0.05; t-test). 
b Significant differences vs controls (P(0.001; t-test). 
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those reported by Wanner et al. [5]. The levels of both FC 
and LCAC were significantly higher in patients than in 
controls (Table 1). Moreover, the LCAC/FC ratio was 
significantly greater in patients than in controls. Erythro- 
cyte CPT is known to have a freely reversible flux, the 
direction of which relies upon the mass action ratio of the 
substrates [ 1]. Because of the high concentrations of FC in 
RBC of hemodialysis patients, the equilibrium of residual 
CPT shifts more likely towards acylcarnitine than towards 
acyl CoA. The observation that the proportion of LCAC to 
FC increases in RBC from hemodialysis patients trongly 
suggests this possibility. Alternatively, the difference in 
the LCAC/FC ratio could result from decreased use of 
fatty acyl groups or increased production. High levels of 
LCAC are known to inhibit RBC Na+-K+-ATPase [13]. In 
addition, molecular dynamics of human membrane [14], its 
stability, as well as its rigidity [6] seem to depend on RBC 
LCAC levels and on the ratio of LCAC to FC. Taken 
together, all these data support hat high levels of LCAC 
and increased proportion of LCAC to FC in RBC may 
contribute to the pathogenesis of the anemia in hemodialy- 
sis patients. 
In conclusion, we suggest hat decreased CPT levels in 
RBC from HD patients alter acyl-trafficking in membrane 
phospholipid fatty acid turnover. The increase in RBC 
LCAC, and particularly in the LCAC/FC ratio, may ac- 
count for, at least in part, some RBC abnormalities in 
hemodiatysis patients. 
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